Cargando…

Engineered ligand‐based VEGFR antagonists with increased receptor binding affinity more effectively inhibit angiogenesis

Pathologic angiogenesis is mediated by the coordinated action of the vascular endothelial growth factor (VEGF)/vascular endothelial growth factor receptor 2 (VEGFR2) signaling axis, along with crosstalk contributed by other receptors, notably α(v)β(3) integrin. We build on earlier work demonstrating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kapur, Shiven, Silverman, Adam P., Ye, Anne Z., Papo, Niv, Jindal, Darren, Blumenkranz, Mark S., Cochran, Jennifer R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412928/ https://www.ncbi.nlm.nih.gov/pubmed/28516164 http://dx.doi.org/10.1002/btm2.10051

Ejemplares similares

Utilizing combinatorial engineering to develop Tie2 targeting antagonistic angiopoetin-2 ligands as candidates for anti-angiogenesis therapy
por: Shlamkovich, Tomer, et al.
Publicado: (2017)

VEGF-A splice variants bind VEGFRs with differential affinities
por: Mamer, Spencer B., et al.
Publicado: (2020)

Engineering Stem Cell Factor Ligands with Different c-Kit Agonistic Potencies
por: Tilayov, Tal, et al.
Publicado: (2020)

Neuropilin-1 functions as a VEGFR2 co-receptor to guide developmental angiogenesis independent of ligand binding
por: Gelfand, Maria V, et al.
Publicado: (2014)

VEGFR-2 conformational switch in response to ligand binding
por: Sarabipour, Sarvenaz, et al.
Publicado: (2016)

Simultaneous targeting of two ligand-binding sites on VEGFR2 using biparatopic Affibody molecules results in dramatically improved affinity
por: Fleetwood, Filippa, et al.
Publicado: (2014)

SH003 represses tumor angiogenesis by blocking VEGF binding to VEGFR2
por: Choi, Hyeong Sim, et al.
Publicado: (2016)

Generating quantitative binding landscapes through fractional binding selections combined with deep sequencing and data normalization
por: Heyne, Michael, et al.
Publicado: (2020)

Andrographolide binds to ATP-binding pocket of VEGFR2 to impede VEGFA-mediated tumor-angiogenesis
por: Kajal, Kirti, et al.
Publicado: (2019)

Allosteric Control of Ligand Binding Affinity Using Engineered Conformation-Specific Effector Proteins
por: Rizk, Shahir S., et al.
Publicado: (2011)

Combinatorial engineering of N-TIMP2 variants that selectively inhibit MMP9 and MMP14 function in the cell
por: Arkadash, Valeria, et al.
Publicado: (2018)

Targeting the Tie2–α(v)β(3) integrin axis with bi-specific reagents for the inhibition of angiogenesis
por: Shlamkovich, Tomer, et al.
Publicado: (2018)

Does a More Precise Chemical Description of Protein–Ligand Complexes Lead to More Accurate Prediction of Binding Affinity?
por: Ballester, Pedro J., et al.
Publicado: (2014)

VEGFR1 signaling in retinal angiogenesis and microinflammation
por: Uemura, Akiyoshi, et al.
Publicado: (2021)

VEGF-dependent tumor angiogenesis requires the inverse and reciprocal regulation of VEGFR1 and VEGFR2
por: Zhang, Zhaocheng, et al.
Publicado: (2009)

VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1- and Galectin-3-Induced Angiogenesis
por: D'Haene, Nicky, et al.
Publicado: (2013)

Computational Modeling to Quantify the Contributions of VEGFR1, VEGFR2, and Lateral Inhibition in Sprouting Angiogenesis
por: Kühn, Clemens, et al.
Publicado: (2019)

Inverting angiogenesis with interstitial flow and chemokine matrix-binding affinity
por: Moure, Adrian, et al.
Publicado: (2022)

Developing a dual VEGF/PDL1 inhibitor based on high-affinity scFv heterodimers as an anti-cancer therapeutic strategy
por: Tzuri, Noam, et al.
Publicado: (2023)

Leak Proof PDBBind: A Reorganized Dataset of Protein-Ligand Complexes for More Generalizable Binding Affinity Prediction
por: Li, Jie, et al.
Publicado: (2023)

Discovery of High-Affinity Protein Binding Ligands – Backwards
por: Diehnelt, Chris W., et al.
Publicado: (2010)

An Efficient Computational Method for Calculating Ligand Binding Affinities
por: Suenaga, Atsushi, et al.
Publicado: (2012)

Identification of high-affinity VEGFR3-binding peptides through a phage-displayed random peptide library
por: Shi, Li-Feng, et al.
Publicado: (2015)

Regulation of Pathologic Retinal Angiogenesis in Mice and Inhibition of VEGF-VEGFR2 Binding by Soluble Heparan Sulfate
por: Nishiguchi, Koji M., et al.
Publicado: (2010)

Discovery of High-Affinity PDGF-VEGFR Interactions: Redefining RTK Dynamics
por: Mamer, Spencer B., et al.
Publicado: (2017)

Probiotic Yeast Inhibits VEGFR Signaling and Angiogenesis in Intestinal Inflammation
por: Chen, Xinhua, et al.
Publicado: (2013)

Accelerated Coronary Angiogenesis by Vegfr1-Knockout Endocardial Cells
por: Zhang, Zheng, et al.
Publicado: (2013)

Tussilagone Suppresses Angiogenesis by Inhibiting the VEGFR2 Signaling Pathway
por: Li, Jia, et al.
Publicado: (2019)

Programmed death ligand‐1 regulates angiogenesis and metastasis by participating in the c‐JUN/VEGFR2 signaling axis in ovarian cancer
por: Yang, Yufei, et al.
Publicado: (2021)

Determination of intracellular protein–ligand binding affinity by competition binding in-cell NMR
por: Luchinat, Enrico, et al.
Publicado: (2021)

Regulation of protein-ligand binding affinity by hydrogen bond pairing
por: Chen, Deliang, et al.
Publicado: (2016)

Influence of length and flexibility of spacers on the binding affinity of divalent ligands
por: Liese, Susanne, et al.
Publicado: (2015)

Applied machine learning for predicting the lanthanide-ligand binding affinities
por: Chaube, Suryanaman, et al.
Publicado: (2020)

Learning protein-ligand binding affinity with atomic environment vectors
por: Meli, Rocco, et al.
Publicado: (2021)

Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression
por: Wang, Min, et al.
Publicado: (2019)

Engineering defensin α‐helix to produce high‐affinity SARS‐CoV‐2 spike protein binding ligands
por: Fernandes, Leonardo Antônio, et al.
Publicado: (2022)

PSnpBind-ML: predicting the effect of binding site mutations on protein-ligand binding affinity
por: Ammar, Ammar, et al.
Publicado: (2023)

Engineering of Bispecific Affinity Proteins with High Affinity for ERBB2 and Adaptable Binding to Albumin
por: Nilvebrant, Johan, et al.
Publicado: (2014)

Low-affinity integrin states have faster ligand-binding kinetics than the high-affinity state
por: Li, Jing, et al.
Publicado: (2021)

Purification of a Novel Anti-VEGFR2 Single Chain Antibody Fragment and Evaluation of Binding Affinity by Surface Plasmon Resonance
por: Kordi, Shirafkan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bo79cj0kaelntcoe4s1i8lgobc